Nippon%20India%20Pharma%20Fund-Growth%20Plan-Growth%20Option Invest Now
Fund Manager: Sailesh Raj Bhan    |     Equity: Sectoral-Pharma and Healthcare    |     S&P BSE Healthcare TRI

424.1005 -0.19 (-0.05 %)

NAV as on 27-03-2024

7,131.66 Cr

AUM as on 29-02-2024

Rtn ( Since Inception )

20.81%

Inception Date

Jun 01, 2004

Expense Ratio

1.84%

Fund Status

Open Ended Scheme

Min. Investment

5,000

Min. Topup

1,000

Min. SIP Amount

100

Risk Status

very high

Investment Objective : The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.